Shaginian, Rimma M.
Eli Lilly (Netherlands)
4 papers on CoChat
Most cited papers
- Verified
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients
Bunck, M. C., Diamant, M., Cornér, A., Eliasson, B., Malloy, J. L., Shaginian, R. M., Deng, W., Kendall, D. M., Taskinen, M.-R., Smith, U., et al. (2009) · Diabetes Care
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 388
- Verified
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes
Bunck, M. C., Cornér, A., Eliasson, B., Heine, R. J., Shaginian, R. M., Taskinen, M.-R., Smith, U., Yki-Järvinen, H., & Diamant, M. (2011) · Diabetes Care
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 240
- Verified
Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
Bunck, M. C., Diamant, M., Eliasson, B., Cornér, A., Shaginian, R. M., Heine, R. J., Taskinen, M.-R., Yki-Järvinen, H., & Smith, U. (2010) · Diabetes Care
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 161
- Verified
One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
Bunck, M. C., Cornér, A., Eliasson, B., Heine, R. J., Shaginian, R. M., Wu, Y., Yan, P., Smith, U., Yki-Järvinen, H., Diamant, M., et al. (2010) · Atherosclerosis
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 132
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free